4.1 Article

Olfactory recovery following omicron variant infection: a psychophysical prospective case-control study with six-month follow up

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination

Luigi Angelo Vaira et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Medicine, General & Internal

Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study

Jerome R. Lechien et al.

Summary: This study investigated the prevalence and recovery of olfactory dysfunction in COVID-19 patients 24 months after the infection. The results showed that approximately 29.8% of patients still experienced persistent olfactory dysfunction after 2 years. Older patients had better olfactory evaluation at baseline, but those with olfactory dysfunction had lower evaluation scores at the end of the follow-up. Olfactory training was associated with better olfactory function at 18 months post-infection.

JOURNAL OF INTERNAL MEDICINE (2023)

Article Otorhinolaryngology

SARS-CoV-2 Effects on Psychophysical Olfactory Scores: Prospective Study With Evaluation Before and 60-Days After Infection

Luigi Angelo Vaira et al.

Summary: The aim of this study was to assess the olfactory function in individuals infected with SARS-CoV-2. The study found that even individuals who did not self-report olfactory dysfunction showed a significant reduction in olfactory function, particularly in the olfactory threshold. These findings highlight the impact of SARS-CoV-2 on the sense of smell.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2023)

Article Otorhinolaryngology

Psychophysical assessment of olfactory and gustatory function in post-mild COVID-19 patients: A matched case-control study with 2-year follow-up

Paolo Boscolo-Rizzo et al.

Summary: The aim of this study was to evaluate the prevalence of smell and taste dysfunction 2 years after mildly symptomatic SARS-CoV-2 infection, taking into account the background of chemosensory dysfunction in the non-COVID-19 population. The results showed that cases of SARS-CoV-2 infection still exhibited a significant excess of olfactory dysfunction 2 years after the infection when compared to matched controls.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2023)

Letter Otorhinolaryngology

COVID-19 related persistent olfactory disorders represent an unprecedented challenge

Luigi Angelo Vaira et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2023)

Article Otorhinolaryngology

Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients

Ahmed Abdelmoneim Teaima et al.

Summary: This study found that most cases of olfactory and gustatory dysfunction caused by COVID-19 infection recover within the first two weeks, with recovery not directly related to olfactory training, treatment received, or patient demographics. Parosmia was identified as an independent predictor for complete recovery, while phantosmia was associated with a lower probability of complete recovery.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Letter Otorhinolaryngology

The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients

Luigi Angelo Vaira et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Article Medicine, Research & Experimental

New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination

Luigi A. Vaira et al.

Summary: This study investigated the clinical profile of patients who developed COVID-19 after full vaccination. Chemosensory dysfunction, particularly olfactory and gustatory dysfunction, was found to be common symptoms, suggesting that sudden loss of smell and taste could continue to be a useful and specific diagnostic marker even in vaccinated subjects.

LARYNGOSCOPE (2022)

Article Multidisciplinary Sciences

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng et al.

Summary: The Omicron variant of SARS-CoV-2 has a higher affinity for ACE2 and can evade neutralizing antibodies more effectively compared to the Delta variant. A third dose of mRNA vaccine can provide enhanced protection. Omicron has lower replication in lung and gut cells and less efficiently cleaves its spike protein compared to Delta.

NATURE (2022)

Article Otorhinolaryngology

Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up

Luigi Angelo Vaira et al.

Summary: This study evaluated olfactory dysfunction in patients after COVID-19 and found that the prevalence of OD was significantly higher in the COVID-19 group compared to the control group, indicating that this result was not affected by the baseline prevalence of OD in the general population.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

Article Otorhinolaryngology

Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study

Luigi Angelo Vaira et al.

Summary: The study found that there was a weak and non-significant correlation between olfactory scores and serum IL-6 levels in COVID-19 patients, casting doubt on the positive prognostic value of olfactory dysfunctions.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Otorhinolaryngology

Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study

Paolo Boscolo-Rizzo et al.

Summary: The study aimed to estimate the 1-year prevalence and recovery rate of self-reported chemosensory dysfunction in patients with previous mild-to-moderate symptomatic COVID-19. The findings showed that 21.3% of patients still reported chemosensory dysfunction 1 year after onset, with 69.5% experiencing complete resolution, 21.9% reporting decreased severity, and 8.6% reporting unchanged or worse symptoms. Patients with higher baseline SNOT-22 scores and longer duration for a negative swab had a higher risk of persistence of symptoms.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Neurosciences

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial

Arianna Di Stadio et al.

Summary: This study found that combining PEA-LUT oral supplements with olfactory training resulted in better recovery of smell among patients with olfactory dysfunction post-COVID-19 compared to olfactory training alone.

CURRENT NEUROPHARMACOLOGY (2022)

Editorial Material Immunology

Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019

Rafal Butowt et al.

Summary: The omicron variant of SARS-CoV-2 causes lower prevalence of anosmia compared to previous variants, possibly due to changes in tissue infection mechanisms. The new mutations make omicron less capable of infecting olfactory cells, thereby sparing olfactory function.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, Research & Experimental

Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia

Aytug Aldundag et al.

Summary: This study retrospectively investigated the effectiveness of modified olfactory training in treating parosmia induced by COVID-19 infection. The results showed that olfactory training was effective in improving parosmia symptoms and increasing discrimination abilities in patients.

LARYNGOSCOPE (2022)

Article Immunology

Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

Salma Sheikh-Mohamed et al.

Summary: Although SARS-CoV-2 mainly infects the upper respiratory tract, little is known about the antibodies generated in the oral cavity in response to COVID-19 vaccination. This study found that most participants had detectable antibodies in their saliva after the first dose of mRNA vaccine. The second dose boosted the IgG response but had little effect on the IgA response. Participants with lower levels of vaccine-induced IgA were more likely to experience breakthrough infections.

MUCOSAL IMMUNOLOGY (2022)

Editorial Material Otorhinolaryngology

Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients

Antonio Matteo Amadu et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Otorhinolaryngology

Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant

Paolo Boscolo-Rizzo et al.

Summary: The prevalence and severity of COVID-19-associated smell and taste dysfunction has significantly decreased with the advent of the Omicron variant but it still remains above 30%.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Allergy

Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)

Ludger Klimek et al.

Summary: Olfactory dysfunction is common in COVID-19, and sudden-onset dysosmia is an early marker for wild-type SARS-CoV-2 infection. A telemedicine-based study compared patients with VOC-Delta or wild-type SARS-CoV-2 infection, showing a significant decrease in olfactory function in both cohorts. VOC-Delta patients had higher olfaction scores at onset of illness and stronger odds of recovery at 4 weeks follow-up compared to WT patients.

WORLD ALLERGY ORGANIZATION JOURNAL (2022)

Article Otorhinolaryngology

Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2-results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)

Constantin A. Hintschich et al.

Summary: This study compared olfactory function in acute SARS-CoV-2 infection between the wild type virus and its variants alpha and delta, and found that patients with the wild type had a higher prevalence of olfactory impairment compared to patients with the variants.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Letter Medicine, General & Internal

Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil

Cynthia Chester Cardoso et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters

Federico Armando et al.

Summary: This study compares virus spread and pathology in Syrian golden hamsters infected with different variants of SARS-CoV-2 and finds that the Omicron variant causes milder pathology.

NATURE COMMUNICATIONS (2022)

Editorial Material Medicine, General & Internal

The burden of prolonged smell and taste loss in covid-19

Nicole Kye Wen Tan et al.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Editorial Material Medicine, General & Internal

Smell and taste dysfunction after covid-19 Health systems are unprepared for the scale of the challenge

Paolo Boscolo-Rizzo et al.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Medicine, General & Internal

Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves

Benjamin Kye Jyn Tan et al.

Summary: This study aims to investigate the recovery rate of smell and taste in patients with COVID-19, the proportion of patients with persistent dysfunction, and the prognostic factors associated with recovery. The findings suggest that a substantial proportion of patients may experience long-term changes in their sense of smell or taste, contributing to the burden of long COVID.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Otorhinolaryngology

Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study

Jerome R. Lechien et al.

Summary: This study investigated the effectiveness of olfactory training (OT) in COVID-19 patients with persistent olfactory dysfunction (OD). The findings showed that adhering to the OT protocol was associated with better mid-term improvement of psychophysical scores. Larger randomized-controlled studies are needed to confirm the effectiveness of OT in COVID-19 patients.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Neurosciences

In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants

Lisa Bauer et al.

Summary: The Delta and Omicron BA.1 variants of SARS-CoV-2 exhibit reduced neuroinvasiveness and neurovirulence compared to the ancestral strain D614G, as shown in in vitro and in vivo experiments.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Infectious Diseases

First cases of Omicron in France are exhibiting mild symptoms, November 2021-January 2022

A. Maisa et al.

Summary: This study investigated the first cases of Omicron detected in France and found that most cases presented with mild symptoms, including young individuals and those who were vaccinated. The findings provide important support for the national COVID-19 surveillance system.

INFECTIOUS DISEASES NOW (2022)

Review Otorhinolaryngology

Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis

Nrusheel Kattar et al.

Summary: Meta-analysis of existing data confirms clinically significant improvements in PVOD associated with OT. There is variability among OT protocols that may benefit from further optimization. Existing data supports the use of OT for the treatment of existing and newly emerging cases of PVOD.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Review Cell Biology

The importance of the olfactory system in human well-being, through nutrition and social behavior

Sanne Boesveldt et al.

Summary: The human sense of smell is underappreciated despite its important functions in warning, protection, eating behavior, and social communication. Beyond influencing appetite and food choice, smell can also impact emotional states and social relationships, contributing to overall well-being.

CELL AND TISSUE RESEARCH (2021)

Article Biochemistry & Molecular Biology

Article Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

Mona Khan et al.

Summary: Anosmia, the loss of smell, is a common symptom of COVID-19, but it is caused by the virus attacking sustentacular cells in the olfactory mucosa rather than infecting olfactory sensory neurons. This suggests that SARS-CoV-2 is not a neurotropic virus.
Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

Article Microbiology

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: Objective evaluation of olfactory function in COVID-19 patients is challenging due to logistical and safety issues. Psychophysical tests provide more accurate results than patient self-reports. Olfactory disturbances appear to be largely independent of epidemiological and clinical characteristics.

PATHOGENS (2021)

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study found that as the time since virus infection increases, olfactory dysfunction becomes more common among patients, with a high percentage showing persistent dysfunction despite most patients subjectively reporting normal smell.

CHEMICAL SENSES (2021)

Article Medicine, General & Internal

Clinical features of patients who had two COVID-19 episodes: a European multicentre case series

J. R. Lechien et al.

Summary: The study found that patients who had two COVID-19 infections had similar clinical features in the second episode as the first, with most patients experiencing milder symptoms in both episodes and shorter duration in the second episode. The occurrence of loss of smell was unpredictable between the first and second infections.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Otorhinolaryngology

Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms

Jerome R. Lechien et al.

Summary: A clinical instrument, the CSI, was developed to evaluate symptoms of COVID-19 patients, showing high internal consistency, validity, and responsiveness to change.

ACTA OTO-LARYNGOLOGICA (2021)

Letter Otorhinolaryngology

New study on prevalence of anosmia in COVID-19 implicates the D614G virus mutation as a major contributing factor to chemosensory dysfunction

Christopher S. von Bartheld et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Otorhinolaryngology

Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers

Juan Riestra-Ayora et al.

Summary: In COVID-19 patients, olfactory and gustatory dysfunction showed high-resolution rates within the first two months after onset, but 11% did not fully recover and 30% partially recovered after 6 months. There was a high correlation between olfactory and gustatory dysfunction, while nasal obstruction and dyspnea were identified as risk factors for symptom persistence.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Otorhinolaryngology

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

M. Petrocelli et al.

Summary: A study found that six months after the onset of COVID-19, about 6% of patients still had severe persistent olfactory or gustatory disturbances.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Article Immunology

Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection

Mariapia Guerrieri et al.

Summary: The study found that mRNA COVID-19 vaccine induces specific immune responses in nasal and salivary secretions against SARS-CoV-2, with stronger effects observed after the second dose of the vaccine. This suggests that mucosal antibody assays could potentially be used for non-invasive monitoring of vaccine-induced protection against viral infection.

VACCINES (2021)

Article Cell Biology

COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters

Guilherme Dias de Melo et al.

Summary: Recent investigations have shown that olfactory and taste dysfunction are common in mildly symptomatic COVID-19 patients. Research on the olfactory neuroepithelium revealed that SARS-CoV-2 infection can cause local inflammation and lead to acute loss of smell, which may account for prolonged symptoms of COVID-19 such as anosmia.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Clinical Neurology

Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction

Sven Saussez et al.

Summary: No clinical markers were found to predict the evolution of olfactory dysfunction (OD) at 60 days. Patients with poor olfactory outcome at 60 days had lower levels of salivary and nasal antibodies, suggesting a role for local immune responses in the persistence of COVID-19 related OD.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Review Otorhinolaryngology

Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: a systematic review

J. Saniasiaya et al.

Summary: Studies show that olfactory dysfunction in COVID-19 patients significantly impacts their quality of life, with 67.7% of patients experiencing deficits. Further research is needed to understand the long-term consequences of persistent olfactory dysfunction.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Article Medicine, Research & Experimental

Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: This study aimed to evaluate the correlations between the severity and duration of olfactory dysfunctions in COVID-19 patients. The presence of OD does not seem to be useful in identifying super-spreaders or predicting long-term OD development. Similarly, the pathogenesis of OD is probably related to individual factors rather than viral load.

LARYNGOSCOPE (2021)

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study prospectively assessed the 6-month prevalence of olfactory dysfunction in subjects with mild-to-moderate COVID-19. Despite most patients reporting a subjectively normal sense of smell, a high percentage of persistent smell dysfunction was observed at 6 months, highlighting a significant long-term rate of smell alteration in patients with previous SARS-CoV-2 infection.

CHEMICAL SENSES (2021)

Article Otorhinolaryngology

Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases

Luigi Angelo Vaira et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

Article Otorhinolaryngology

Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts

Alberto Paderno et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Article Otorhinolaryngology

Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study

Eleonore Chary et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2020)

Article Otorhinolaryngology

Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Article Otorhinolaryngology

Prognosis of postviral olfactory loss: Follow-up study for longer than one year

Doh Young Lee et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2014)